Cargando…
Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer
Neoadjuvant chemotherapy for breast cancer has a well-established role in the management of patients with locally advanced or early stage disease. Multiple trials have demonstrated superior survival outcomes in individuals achieving a pathologic complete response at the time of definitive surgery, a...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2242653/ https://www.ncbi.nlm.nih.gov/pubmed/17888189 http://dx.doi.org/10.1186/bcr1755 |